论文部分内容阅读
Although patients with acute lymphoblastic leukemia (ALL) usually achieve complete remission, disease relapse is common and difficult to treat, necessitating new strategies for the treatment of ALL.NO-aspirin is a novel drug that has efficacy against a number of solid tumors.This drug can inhibit Wnt signaling, which we have shown to be important for ALL cell proliferation and survival.Treatment of B lineage ALL cell lines and patient ALL samples with NO-aspirin resulted in rapid apoptotic cell death.